Back to Search
Start Over
Impact of Converting from Immediate-Release Tacrolimus to Envarsus on BK Viremia Incidence in Kidney Transplant Patients with Rapid Metabolism.
- Source :
-
Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2023 May 25; Vol. 29, pp. e939748. Date of Electronic Publication: 2023 May 25. - Publication Year :
- 2023
-
Abstract
- BACKGROUND BK infections have been observed more frequently among people who are rapid metabolizers. The tacrolimus c/d ratio identifies rapid metabolizers after transplantation. Envarsus has a lower peak drug level exposure than tacrolimus and is more pronounced in rapid metabolizers. This study hypothesized that less exposure to high tacrolimus levels through use of Envarsus would reduce the incidence of BK infections. MATERIAL AND METHODS This study prospectively converted 43 consecutive kidney transplant recipients (identified as rapid metabolizers by c/d ratio of.
- Subjects :
- Humans
Incidence
Transplant Recipients
BK Virus
Immunosuppressive Agents adverse effects
Kidney Transplantation adverse effects
Tacrolimus adverse effects
Viremia epidemiology
Polyomavirus Infections drug therapy
Polyomavirus Infections epidemiology
Tumor Virus Infections drug therapy
Tumor Virus Infections epidemiology
Subjects
Details
- Language :
- English
- ISSN :
- 1643-3750
- Volume :
- 29
- Database :
- MEDLINE
- Journal :
- Medical science monitor : international medical journal of experimental and clinical research
- Publication Type :
- Academic Journal
- Accession number :
- 37272339
- Full Text :
- https://doi.org/10.12659/MSM.939748